Literature DB >> 16965723

Treatment of isolated systolic hypertension.

Gordon S Stokes1.   

Abstract

Isolated systolic hypertension (ISH) is the dominant form of hypertension in the elderly. It is associated with increased arterial pulse pressure, to which an early-returning and magnified pulse-wave reflection makes an important contribution. Treatment of ISH with diuretics, calcium channel blockers (CCBs), and angiotensin II inhibitors is effective in reducing systolic blood pressure, preventing cardiovascular morbid events, and lowering mortality; these agents may have to be used in combination to achieve the systolic blood pressure goal of < 140 mm Hg. Treatment with beta-blockers appears to be less effective. The relative efficacy of various classes of antihypertensive drugs for lowering pulse pressure and systolic blood pressure is determined in part by their differing abilities to reduce pulse-wave reflection. In patients with ISH that is refractory to dual or triple therapy, measurement of the reflected wave by applanation tonometry may be useful in determining which additional antihypertensive agent to use.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16965723     DOI: 10.1007/s11906-006-0081-0

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  41 in total

1.  Aerobic exercise training does not modify large-artery compliance in isolated systolic hypertension.

Authors:  K E Ferrier; T K Waddell; C D Gatzka; J D Cameron; A M Dart; B A Kingwell
Journal:  Hypertension       Date:  2001-08       Impact factor: 10.190

2.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

3.  Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators.

Authors:  J A Staessen; L Thijs; R Fagard; E T O'Brien; D Clement; P W de Leeuw; G Mancia; C Nachev; P Palatini; G Parati; J Tuomilehto; J Webster
Journal:  JAMA       Date:  1999-08-11       Impact factor: 56.272

4.  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

Authors: 
Journal:  JAMA       Date:  1991-06-26       Impact factor: 56.272

5.  Low mineral intake is associated with high systolic blood pressure in the Third and Fourth National Health and Nutrition Examination Surveys: could we all be right?

Authors:  Marilyn S Townsend; Victor L Fulgoni; Judith S Stern; Seth Adu-Afarwuah; David A McCarron
Journal:  Am J Hypertens       Date:  2005-02       Impact factor: 2.689

6.  Definitions and characteristics of sodium sensitivity and blood pressure resistance.

Authors:  M H Weinberger; J Z Miller; F C Luft; C E Grim; N S Fineberg
Journal:  Hypertension       Date:  1986-06       Impact factor: 10.190

7.  Dietary sodium restriction rapidly improves large elastic artery compliance in older adults with systolic hypertension.

Authors:  Phillip E Gates; Hirofumi Tanaka; William R Hiatt; Douglas R Seals
Journal:  Hypertension       Date:  2004-06-01       Impact factor: 10.190

8.  Are beta-blockers efficacious as first-line therapy for hypertension in the elderly? A systematic review.

Authors:  F H Messerli; E Grossman; U Goldbourt
Journal:  JAMA       Date:  1998-06-17       Impact factor: 56.272

9.  The effects of losartan compared to atenolol on stroke in patients with isolated systolic hypertension and left ventricular hypertrophy. The LIFE study.

Authors:  Sverre E Kjeldsen; Paulette A Lyle; Jorge R Kizer; Björn Dahlöf; Richard B Devereux; Stevo Julius; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristianson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Steven M Snapinn; Katherine E Harris; Hans Wedel
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-03       Impact factor: 3.738

10.  Changes in the continuation of antihypertensive drug use after ALLHAT.

Authors:  Fagen Xie; Diana B Petitti; Joel Handler
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-11       Impact factor: 3.738

View more
  2 in total

1.  Untreated Isolated Sytolic Hypertension among Middle-Aged and Old Adults in the United States: Trends in the Prevalence by Demographic Factors During 1999-2010.

Authors:  Xuefeng Liu; Van Minh Hoang; Yali Liu; Rachel L W Brown
Journal:  Int J Chronic Dis       Date:  2015-02-23

2.  Lowering blood pressure with beta-blockers in combination with other renin-angiotensin system blockers in patients with hypertension and type 2 diabetes: results from the GEMINI Trial.

Authors:  Jackson T Wright; George L Bakris; David S H Bell; Vivian Fonseca; Richard E Katholi; Janet B McGill; Franz H Messerli; Robert A Phillips; Philip Raskin; Fred K Holdbrook; Mary Ann Lukas; Malini Iyengar
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-11       Impact factor: 3.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.